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Caesarean section (CS) commonly induces moderate to 
severe pain for 48 hours.1 The aims of postoperative pain 
treatment are to provide subjective comfort, inhibit 
nociceptive impulses and blunt the neuro-endocrine 
response to pain thus enhancing the restoration of 
function.2
CS patients have additional compelling reasons to 
provide adequate pain relief, as early mobilization is 
a key factor to prevent the risk of thrombo-embolic 
disease, which is increased during pregnancy. Besides 
these patients need to be pain free to care for their 
newborn and breastfeed them effectively.
Role of Opioids: Historically opioids are most 
commonly administered analgesia for postoperative 
CS pain management. They are used both systemically 
and neuraxially for postoperative analgesia. Systemic 
administration is mostly used after general anaesthesia 
and in places where there is unavailability of long 
acting preservative free opioids or lack of expertise in 
its usage. Systemic routes for opioids administration 
are intramuscular and intravenous, given either 
intermittently, on demand basis or by intravenous 
continuous method.
These methods do not take into account the very 
large variability of the responses of patients, and are 
all dependent upon the interpretation of nurses and 
prescription by physicians. Recently Landau3 tried to 
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individualize anaesthestic care during caesarean section 
by identifying some genetic polymorphisms. He 
concluded that “genetic test” might become a useful 
bedside screening tool to predict the development of 
chronic pain and to individualize postoperative pain 
therapy.
The limitation of individual patient’s variability and 
fluctuating blood level of analgesic is overcome to some 
extent by the use of patient controlled intravenous 
analgesia (IV-PCA). Pain relief with IV-PCA has 
shown to be superior to conventional intramuscular 
opioids for women having had a caesarean section.4 In 
one of our randomized controlled trial of intravenous 
patient controlled analgesia (IV-PCA) with continuous 
opioid infusion (in press) in post caesarean section 
patients, we found better pain score at 6, 12 and 24 
hours postoperatively, less need for rescue analgesia 
and better pain satisfaction. Patients’ own control 
over their pain management may have allowed them 
to obtain an opioid bolus at the initial feeling of pain, 
without having to wait for the nurses and doctors to 
provide analgesia. This has resulted in overall improved 
analgesia. Despite being less efficacious than neuraxial 
administration, patient satisfaction scores are highest 
with IV-PCA.5,6
It has been almost 32 years since Neuraxial opioids 
first underwent rigorous clinical study for use in 
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humans.7 Several large reviews indicate that the 
neuraxial approach provide superior analgesia over 
systemic administration.5 Preservative-free morphine is 
perhaps the most popular adjuvant administered either 
intrathecally or epidurally in many countries. It provides 
proven and significantly prolonged postoperative 
analgesia with a reduction in postoperative analgesic 
requirement. A meta-analysis of intrathecal opioid 
studies revealed that intrathecal morphine (0.1-0.2 mg) 
provided optimal analgesia with a median time to first 
request for supplemental analgesia of 27 hours (range 
11-29 hours), in addition to reducing pain scores and 
the amount of supplemental analgesics needed for 24 
hours postoperatively.8
Other opioids like fentanyl, sufentanil, diamorphine, 
hydromorphone, meperidine, buprenorphine and 
nalbuphine have been administered neuraxially for 
postoperative analgesia but more rarely.
Limitation to the use of opioids: Pain, pruritus, 
nausea/vomiting, sedation and respiratory depression 
are concerning issues that complicate postoperative 
opioid usage. The incidence of respiratory depression 
is not known but is probably low.9,10 Nevertheless, 
frequent monitoring of vital signs and/or respiratory 
pattern is important to prevent such rare mishaps.
These limitations have led to the introduction of use of 
multimodal analgesia in the form of:
Co-analgesic/ adjuvant drugs.	
Nerve block and wound infiltration	
The goal is to obtain synergistic or additive analgesia 
with fewer side effects by combining lesser amounts 
of each drug with different mechanisms of action. 
The anti-inflammatory and antipyretic properties 
of non-steroidal anti-inflammatory drugs (NSAIDs) 
may reduce visceral pain originating from the uterus, 
complementing the somatic wound pain relief from 
the opioid. The addition of NSAIDs has been shown to 
potentiate opioid effect, decrease opioid consumption 
and reduce side effects when systemic or neuraxial 
opioids are administered for post cesarean delivery 
analgesia.10,11 NSAIDs must be used with caution 
because of the potential problems with bleeding, platelet 
dysfunction and renal insufficiency although practice 
varies widely in this matter. A systematic review of 
36 studies on 3362 patients comparing efficacy of 
adding acetaminophen (paracetamol) or its precursor, 
NSAIDs or their combinations to postoperative opioid 
pain management suggests acetaminophen is a useful 
alternative with low incidence of adverse effects and 
with mostly similar or slightly less efficacy (depending 
on types of surgery) compared to NSAIDs. However, 
the data on enhanced analgesic efficacy, if any, from 
adding acetaminophen to NSAIDs require further 
investigation especially on the potential increase of side 
effects from their combined use.12 A randomized, double 
blind controlled trial13 comparing the postoperative 
analgesic effects of IV acetaminophen with those of 
oral ibuprofen in patients receiving IV-PCA after CS 
showed equal analgesic profile to oral ibuprofen and 
therefore can be used in patients where NSAIDs are 
contraindicated.
A newer COX-2 inhibitor, (parecoxib) was compared 
with ketorolac combined with morphine on IV-PCA 
in post CS pain management.14 It was found to have 
efficacy-equating ketorolac with PCA morphine for an 
opioid sparing effect. Preoperative gabapentin 600mg 
in the setting of multimodal analgesia reduces post CS 
pain and increase maternal satisfaction but 19% of the 
patient had severe sedation as compared to 0% in the 
controlled group but there was no difference in the 
Apgar score or umbilical artery pH.15
A number of clinical studies have examined the 
effects of other adjuvant medications administered 
neuraxially for enhancing postoperative analgesia, but 
each has been associated with various degrees of side 
effects. Use of neuraxial neostigmine is limited by its 
high incidence of prolonged motor blockade, nausea 
and vomiting even with spinal doses as low as 6.25 μg.16 
Clinical studies with the use of neuraxial clonidine (a 
Lipophilic α2-adrenergic agonist), when combined 
with an opioid prolongs analgesia, reduce opioid 
consumption and decrease shivering, but hypotension, 
dose-dependent sedation, bradycardia, prolonged motor 
blockade and perioperative vomiting are common side 
effects occurring in similar frequency in women after 
cesarean delivery as in other post surgical populations.17 
Besides the high cost of clonidine in the US, it also 
carries an FDA “black box” warning against neuraxial 
use in obstetrical, postpartum and perioperative pain 
management because of its potential hemodynamic 
side effects.
Dexmedetomidine, also a α2-adrenergic agonist 
approved only for intravenous use, has similar side 
effects as clonidine and there is limited information 
on neonatal effect and postpartum or post cesarean 
delivery usage. Clinical data are too limited in 
obstetrical and postpartum populations to offer 
meaningful clinical recommendations on some of the 
potentially useful agents currently under investigation 
such as the N-methyl-D-aspartate (NMDA) receptor 
antagonist dextromethorphan, the anticonvulsant 
gabapentin and the cycloxygenase inhibitor Ketorolac 
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given intrathecally.
The NICE guidelines for cesarean sections suggest that 
wound infiltration and/or ilioinguinal nerve block 
are viable alternatives to systemic analgesia.18 Ranta 
et al. report the subfascial catheter administration 
of levobupivacaine following cesarean delivery to 
be a useful and safe component of multimodal pain 
management and a viable alternative to epidural 
analgesia.19  The improvement in modern elastometric 
balloon pump design also enables the ease of application 
for wound analgesic infiltration technique without 
hindering ambulation or caring for the newborn. 
Ranta and her colleagues’ results are encouraging 
and provide support for such an adjuvant modality 
in postoperative analgesia, especially in women 
undergoing general anesthesia for caesarean delivery.19 
The Cochrane database of 2009 indicates that local 
analgesia infiltration and abdominal nerve block as 
adjunct to regional analgesia and general anaesthesia 
are of benefit in caesarean section by reducing opioid 
consumption.20
Transversus Abdominis Plane (TAP) block was 
first described in 2001 by Dr Rafi21 and was further 
developed and tested by McDonnell et al.22 It involves 
peripheral block of the anterior abdominal wall. A 
meta-analysis23 to study the efficacy of TAP block 
shows that it reduces the need for postoperative 
opioid, the time for first request for further analgesia, 
provides more effective pain relief and reduces opioid 
associated side effects. However there are conflicting 
results of TAP block in two studies done on post CS 
patients. 24,25  Both studies have used ultrasound-guided 
technique for TAP block. Costello et al24 have used it, 
as part of multimodal analgesia along with long acting 
intrathecal opioid did not find any improved quality 
of analgesia for post CS patients. Similarly one study26 
comparing intrathecal morphine with TAP block 
showed superior analgesia with intrathecal morphine 
but more side effects compared to TAP block group. 
However Belavy et al25 using TAP block as a part of 
multimodal analgesia with long acting opioid and using 
IV-PCA morphine postoperatively, showed improved 
pain score, higher patient satisfaction score and opioid-
sparing effect and reduced use of antiemetic in women 
undergoing CS. Therefore TAP block can be a better 
option for patients not receiving long acting neuraxial 
opioids. 
Have we reached the standard?: Noblet and Plaat 
have raised an interesting point about the unachievable 
standard suggested by the Royal College of Anaesthetists 
(RCoA).27,28 The standard suggests that >90% of 
women should score their worst pain as <3 on VAS 
of 0-10. We did an audit in our unit and found that 
39.8% of women had VAS score of >3. A literature 
search revealed that we are not the only one failing this 
target.27,29,30 The result of these studies and our results 
showed a patient satisfaction of >90%. Therefore, this 
raises the question of the need to reconsider pain relief 
and its assessment in CS patient.
Developing countries face another challenge of limited 
supply of opioids, lack of long acting intrathecal 
preservative free narcotic and expertise for its use. In 
our observational study on the technique of anaesthesia 
(in press), we determined that general anaesthesia is 
still used in 49% of cases and in another study (in press) 
we determined that continuous opioid infusion was 
the most common method of postoperative analgesia 
after CS in our institution and pethidine was the 
most common opioid used. One study done in rural 
health district of South Africa31 has shown pethidine 
(69%) as the most common opioid prescribed after 
CS and intramuscular route was the only route of 
administration.
CONCLUSION
Women having CS presents a unique set of problems to 
the anaesthetist and requires optimal pain management. 
We need to explore the possibility to establish standard 
pain relief methods; the choice should be determined 
by drug availability, resource limitations and financial 
consideration.
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